Sentence examples for medication adherence self-efficacy from inspiring English sources

To examine the associations of provider patient communication, glaucoma medication adherence self-efficacy, and outcome expectations with glaucoma medication adherence.

Level of symptoms was correlated negatively and significantly with self-reported medication adherence and medication adherence self-efficacy.

We used previously validated survey tools on illness beliefs and medication adherence self-efficacy, but the validation was not done in an Afro-Caribbean population and these scales may not accurately reflect true perspectives of our target population [17, 18].

Adherence behavioral skills were assessed with the revised Medication Adherence Self-Efficacy Scale (MASES-R), which is a reliable and valid measure of medication adherence self-efficacy (33).

The third part included questions about medication adherence self-efficacy, reasons for missing doses, and adherence aids.

The Medication Adherence Self-efficacy Scale (MASES) [ 28] has 26 questions identifying difficult situations affecting medication self-efficacy, with 'not at all sure'somewhathat sure' and 'very sure' answers, takes about five minutes to complete and has a Cronbach's α coefficient of 0.95.

The aim of the study was to evaluate the relationship between elevated systolic BP in the ED and a previous diagnosis of HTN, accounting for potential factors that could contribute to poor HTN control among those with a previous diagnosis: socioeconomic status, health-seeking behavior, underlying HTN illness beliefs, medication adherence, and perceived adherence self-efficacy.

Some of these factors are adherence self-efficacy, frequency of dosing, medication beliefs, forgetfulness, alcohol use, depression, unemployment and misunderstandings about the prescription [ 6, 37- 39].

Secondary outcome measures included: assessment of medication adherence, medication self-efficacy and general wellbeing.

Secondary aims were to determine the effectiveness of the intervention on medication adherence, medication self-efficacy and general wellbeing in consumers with co-existing diabetes and chronic kidney disease.

The extent of the relationship between pill counts, self-report of medication adherence and self-efficacy, and other clinical and surrogate biochemical markers of disease control will also be evaluated.